Holen Sie sich die Stockscreener-App
123.13
0.09%
0.11
Handel nachbörslich:
123.13
State Street Spdr S P Biotech Etf Aktie (XBI) Neueste Nachrichten
Eight stock picks to play one of the healthiest corners of the market - MarketWatch
Opinion: The Fed cut rates. Biotech didn’t notice. - MarketWatch
Biotech ETF (XBI) Hits New 52-Week High - TradingView
The Biotech Industry Is Healthier Than Investors Think. The Stocks to Watch. - Barron's
Meet the New AI Winners: Alphabet, Tesla and Even Big Pharma and Biotech - Barron's
Two Sector ETFs Are Quietly Outperforming the S&P 500 Without a Single AI Stock - AOL.com
1 Sector ETF to Avoid Like the Plague in November - AOL.com
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - sharewise.com
ETFs Investing in ArriVent BioPharma, Inc. Stocks - TradingView
Gold Miners Are Crushing Gold: UBS Says Grab These 5 Cheap Picks - AOL.com
IYK vs. XLP: Top Holdings Could Make the Difference - AOL.com
State Street SPDR and iShares ETFs Deliver Strong Growth Without AI Stocks - cointurk finance
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - sharewise.com
This Fund Leaned Into 2025's Big Biotech Rally with a $9.5 Million Bet on Mineralys - AOL.com
Biotech Fund Dumps $12.3 Million in Crinetics Stock as Shares Remain 19% Lower on the Year - AOL.com
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Apple, Taiwan Semiconductor Manufacturing And More On CNBC's 'Final Trades' - Benzinga
The Zacks Analyst Blog Highlights LLY, EPHE, BBC, HELX, XHS and SURI - sharewise.com
Best-Performing ETFs of Last Week: Healthcare Rules - sharewise.com
Why biotech and drug stocks are on the mend even though the rest of the market is hurting - MSN
3 Biotech Stocks Wall Street Analysts Predict Will More Than Double - MSN
ETFs Investing in Janux Therapeutics, Inc. Stocks - TradingView
S&P 500: Health Care Stocks Come Alive — Nudging Tech Aside For Now - Investor's Business Daily
Biotech Stock Gets Booted in Latest Fund Update - AOL.com
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - sharewise.com
(11/19/25) PFE: The Winner in the Metsera Bidding War - moneyshow.com
Why biotech and drug stocks are rallying even though the rest of the market is hurting - MSN
M&A Injects Life Into Biotech Trade - TheStreet Pro
XBI: Biotech Funding Condition Recovery Could Be Overdue (NYSEARCA:XBI) - Seeking Alpha
XBI: An Equal Weight ETF On Biotech That Amplifies Its Speculative Component - Seeking Alpha
Breakthrough bets on life sciences rebound with $430m fundraise - Private Equity Real Estate | PERE
This Biotech Stock Soared 100%. Merck Is Buying It. - Barron's
META_TITLE_SECTORS - Yahoo Finance
Money Moving Into Healthcare Not AI; Four Fed Presidents Do Not Want a Rate Cut; Euphoria Wearing Off - Sahm
Two Biotech Stocks to Watch as Sector Bounces Back - TheStreet Pro
2 Aggressive Growth ETFs That Can Beat the Market - AOL.com
Should You Invest in the State Street SPDR S&P Semiconductor ETF (XSD)? - Yahoo Finance
Should You Invest in the State Street SPDR S&P Oil & Gas Exploration & Production ETF (XOP)? - Nasdaq
Is State Street SPDR S&P Retail ETF (XRT) a Strong ETF Right Now? - sharewise.com
Is State Street SPDR S&P Bank ETF (KBE) a Strong ETF Right Now? - Yahoo Finance
Should You Invest in the State Street SPDR S&P Retail ETF (XRT)? - Nasdaq
Is the Drought in Life-Sciences IPOs Over? Two Startups Will Test Demand - The Wall Street Journal
Need Income? These 3 Dividend ETFs Pay You 52 Times Per Year - AOL.com
0.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):